Glass Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-53,223
Closed -$2.21M 56
2024
Q2
$2.21M Sell
53,223
-6,560
-11% -$294K 1.29% 33
2024
Q1
$3.24M Buy
+59,783
New +$3.05M 1.98% 18

Other funds holding BMY

Glass Wealth Management's BMY Position: Q3 2024 in Review

Glass Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2024, closing a stake of 53,223 shares — an estimated $2.21M sold.

Glass Wealth Management first reported a position in BMY in Q1 2024 and held it in 2 quarters. The position peaked at $3.24M in Q1 2024. 2,258 funds tracked by Wall St. Rank hold BMY as of Q3 2024.

  • Glass Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2024 after selling out during the quarter.
  • Glass Wealth Management sold 53,223 Bristol-Myers Squibb shares in Q3 2024, an estimated $2.21M.
  • Glass Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2024 and held it in 2 quarters.
  • Glass Wealth Management's Bristol-Myers Squibb position peaked at $3.24M in Q1 2024.
  • 2,258 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2024.

Based on Glass Wealth Management's 13F filing for Q3 2024, filed 7 Nov 2024.